BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17599093)

  • 1. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
    Edamura K; Nasu Y; Takaishi M; Kobayashi T; Abarzua F; Sakaguchi M; Kashiwakura Y; Ebara S; Saika T; Watanabe M; Huh NH; Kumon H
    Cancer Gene Ther; 2007 Sep; 14(9):765-72. PubMed ID: 17599093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
    Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
    Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
    Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
    Sugimoto M; Watanabe M; Kaku H; Li SA; Noguchi H; Ueki H; Sakaguchi M; Huh NH; Nasu Y; Kumon H
    Oncol Rep; 2012 Nov; 28(5):1645-52. PubMed ID: 22941469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3.
    Abarzua F; Sakaguchi M; Tanimoto R; Sonegawa H; Li DW; Edamura K; Kobayashi T; Watanabe M; Kashiwakura Y; Kaku H; Saika T; Nakamura K; Nasu Y; Kumon H; Huh NH
    Int J Mol Med; 2007 Jul; 20(1):37-43. PubMed ID: 17549386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ transduction of cytosine deaminase gene followed by systemic use of 5-fluorocytosine inhibits tumor growth and metastasis in orthotopic prostate cancer mouse models.
    Zhang Z; Yin L; Zhang Y; Zhao F
    Chin Med J (Engl); 2002 Feb; 115(2):227-31. PubMed ID: 11940337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
    Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
    Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
    Hsieh SY; Hsieh PS; Chiu CT; Chen WY
    Oncogene; 2004 Dec; 23(57):9183-9. PubMed ID: 15516983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
    Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
    Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
    Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
    Kawauchi K; Watanabe M; Kaku H; Huang P; Sasaki K; Sakaguchi M; Ochiai K; Huh NH; Nasu Y; Kumon H
    Acta Med Okayama; 2012; 66(1):7-16. PubMed ID: 22358134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
    Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
    Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
    Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
    Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
    Jin Y; Murata H; Sakaguchi M; Kataoka K; Watanabe M; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2012 Mar; 27(3):695-9. PubMed ID: 22076283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated N5 gene transfer inhibits tumor growth and metastasis of human carcinoma in nude mice.
    Yin S; Bailiang W; Xie K; Goodrich DW
    Cancer Gene Ther; 2002 Aug; 9(8):665-72. PubMed ID: 12136427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
    Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
    Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.